BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bui S, Masson A, Enaud R, Roditis L, Dournes G, Galode F, Collet C, Mas E, Languepin J, Fayon M, Beaufils F, Mittaine M. Long-Term Outcomes in Real Life of Lumacaftor-Ivacaftor Treatment in Adolescents With Cystic Fibrosis. Front Pediatr 2021;9:744705. [PMID: 34869102 DOI: 10.3389/fped.2021.744705] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Dittrich A, Chuang SY. Dual CFTR modulator therapy efficacy in the real world: lessons for the future. ERJ Open Res 2022;8:00464-2022. [DOI: 10.1183/23120541.00464-2022] [Reference Citation Analysis]
2 Dobra R, Bentley S, Edmondson C, Ovens M, Saunders C, Short C, Wilson G, Davies JC, Bush A. Going the Extra Mile: Why Clinical Research in Cystic Fibrosis Must Include Children. Children 2022;9:1080. [DOI: 10.3390/children9071080] [Reference Citation Analysis]
3 Regard L, Martin C, Burnet E, Da Silva J, Burgel P. CFTR Modulators in People with Cystic Fibrosis: Real-World Evidence in France. Cells 2022;11:1769. [DOI: 10.3390/cells11111769] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Korten I, Kieninger E, Krueger L, Bullo M, Flück CE, Latzin P, Casaulta C, Boettcher C. Short-Term Effects of Elexacaftor/Tezacaftor/Ivacaftor Combination on Glucose Tolerance in Young People With Cystic Fibrosis—An Observational Pilot Study. Front Pediatr 2022;10:852551. [DOI: 10.3389/fped.2022.852551] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Wucherpfennig L, Triphan SM, Wege S, Kauczor H, Heussel CP, Schmitt N, Wuennemann F, Mayer VL, Sommerburg O, Mall MA, Eichinger M, Wielpütz MO. Magnetic resonance imaging detects improvements of pulmonary and paranasal sinus abnormalities in response to elexacaftor/tezacaftor/ivacaftor therapy in adults with cystic fibrosis. Journal of Cystic Fibrosis 2022. [DOI: 10.1016/j.jcf.2022.03.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]